Pfizer (PFE) EBITDA (2009 - 2026)
Pfizer (PFE) recorded EBITDA of $5.89 billion in Q2 2026, down 11.8% from $6.68 billion a year earlier and down 15.5% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) EBITDA (2009 - 2026) Analysis & Trends
On a TTM basis, Pfizer's EBITDA came in at $26.98 billion as of Jun 28, 2026, up 0.4% year-over-year; for FY2025, it came in at $27.32 billion, up 10.1% from FY2024.
- Annual EBITDA has a five-year compound annual growth rate of 10.0% (FY2020 to FY2025).
- Across earlier years, EBITDA came in at $24.82 billion in FY2024 (+98.6%), $12.5 billion in FY2023 (-72.5%), $45.42 billion in FY2022 (+42.8%) and $31.79 billion in FY2021 (+87.4%).
- The Q2 2026 figure is the lowest quarterly EBITDA since Q4 2024.
- On a year-over-year basis, EBITDA rose in four of the last six quarters, with growth averaging 9.9%.
- Peak year-over-year performance for EBITDA in the last five years was growth of 103.7% in Q3 2021, against a decline of 64.9% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.97 billion (Q1 2026), $6 billion (Q4 2025) and $8.13 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Bristol Myers Squibb | 130.49 Bn | 81.76 Bn | 9.25 Bn | 954.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 5.89 Bn |
| Mar 29, 2026 | 6.97 Bn |
| Dec 31, 2025 | 6.00 Bn |
| Sep 28, 2025 | 8.13 Bn |
| Jun 29, 2025 | 6.68 Bn |
| Mar 30, 2025 | 6.58 Bn |
| Dec 31, 2024 | 5.59 Bn |
| Sep 29, 2024 | 8.04 Bn |
| Jun 30, 2024 | 4.05 Bn |
| Mar 31, 2024 | 7.15 Bn |
| Dec 31, 2023 | -1.28 Bn |
| Jul 2, 2023 | 4.98 Bn |
| Apr 2, 2023 | 9.21 Bn |
| Dec 31, 2022 | 6.75 Bn |
| Jul 3, 2022 | 14.22 Bn |
| Apr 3, 2022 | 11.78 Bn |
| Dec 31, 2021 | 5.16 Bn |
| Oct 3, 2021 | 9.22 Bn |
| Jul 4, 2021 | 8.05 Bn |
| Apr 4, 2021 | 6.77 Bn |
API Access
Pfizer EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();